| TTHM | Health-Based | N/A | 0.081 | Jun 30, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | May 10, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 6, 2025 | Active | N/A |
| TTHM | Health-Based | N/A | 0.081 | Mar 31, 2025 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.081 | Mar 31, 2025 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.081 | Mar 31, 2025 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2025 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jan 21, 2025 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Dec 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Sep 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jul 30, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | May 20, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 3, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2024 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jan 18, 2024 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 11, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 3, 2023 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.016 | Sep 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Sep 24, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Sep 13, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 5, 2023 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Groundwater Rule | Health-Based | N/A | N/A | May 28, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | May 28, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | May 28, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | May 28, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | May 28, 2023 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | May 28, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 22, 2023 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jan 17, 2023 | Active | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Dec 13, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 13, 2022 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 8, 2022 | Active | N/A |
| TTHM | Health-Based | N/A | 0.081 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.081 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.081 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.081 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.081 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.081 | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.012 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jul 10, 2022 | Active | N/A |
| Lead and Copper Rule | Health-Based | N/A | N/A | Jul 10, 2022 | Active | N/A |
| TTHM | Health-Based | N/A | 0.085 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.085 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.085 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.085 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.085 | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | May 16, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 16, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Apr 26, 2022 | Active | N/A |
| TTHM | Health-Based | N/A | 0.086 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.086 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.086 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.086 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.086 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 0.086 | Mar 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 23, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 23, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 23, 2021 | Resolved | N/A |